{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T14:52:08Z","timestamp":1782226328994,"version":"3.54.5"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2011,11,8]],"date-time":"2011-11-08T00:00:00Z","timestamp":1320710400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1007\/s12185-011-0966-9","type":"journal-article","created":{"date-parts":[[2011,11,7]],"date-time":"2011-11-07T05:01:20Z","timestamp":1320642080000},"page":"571-575","source":"Crossref","is-referenced-by-count":15,"title":["Symptomatic severe hypertriglyceridaemia with asparaginase therapy in acute lymphoblastic leukaemia (ALL) and lymphoblastic lymphoma: is rechallenging safe?"],"prefix":"10.1007","volume":"94","author":[{"given":"Harsha Prasada","family":"Lashkari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Lancaster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayad","family":"Atra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Champion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary M.","family":"Taj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,11,8]]},"reference":[{"key":"966_CR1","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1182\/blood.V97.5.1211","volume":"97","author":"LB Silverman","year":"2001","unstructured":"Silverman LB, Gelber RD, Dalton VK, et al. Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91\u201301. Blood. 2001;97:1211\u20138.","journal-title":"Blood"},{"key":"966_CR2","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/1097-0142(197002)25:2<253::AID-CNCR2820250204>3.0.CO;2-U","volume":"25","author":"HF Oettgen","year":"1970","unstructured":"Oettgen HF, Stephenson PA, Schwartz MK, et al. Toxicity of E. coli l-asparaginase in man. Cancer. 1970;25:253\u201378.","journal-title":"Cancer"},{"key":"966_CR3","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1182\/blood.V112.11.337.337","volume":"112","author":"A Vora","year":"2008","unstructured":"Vora A, Wade R, Mitchell C. Efficacy, toxicity of pegylated asparaginase in the treatment of children, young adults with acute lymphoblastic leukaemia: results of the United Kingdom Medical Research Council (MRC) trial UKALL 2003. Blood. 2008;112:337.","journal-title":"Blood"},{"key":"966_CR4","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0021-9150(01)00656-6","volume":"161","author":"RS Rosenson","year":"2002","unstructured":"Rosenson RS, Shott S, Tangney CC. Hypertriglyceridemia is associated with an elevated blood viscosity Rosenson: triglycerides and blood viscosity. Atherosclerosis. 2002;161:433\u20139.","journal-title":"Atherosclerosis"},{"key":"966_CR5","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/00004836-200301000-00016","volume":"36","author":"D Yadav","year":"2003","unstructured":"Yadav D, Pitchumoni CS. Issues in hyperlipidemic pancreatitis. J Clin Gastroenterol. 2003;36:54\u201362.","journal-title":"J Clin Gastroenterol"},{"key":"966_CR6","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1365-2141.2010.08132.x","volume":"149","author":"A Qureshi","year":"2010","unstructured":"Qureshi A, Mitchell C, Richards S, et al. Asparaginase-related venous thrombosis in UKALL. Br J Haematol. 2010;149:410\u20133.","journal-title":"Br J Haematol"},{"key":"966_CR7","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1182\/blood.V89.6.1886","volume":"89","author":"SK Parsons","year":"1997","unstructured":"Parsons SK, Skapek SX, Neufeld EJ, et al. Asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia. Blood. 1997;89:1886\u201395.","journal-title":"Blood"},{"key":"966_CR8","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/pbc.22305","volume":"54","author":"H Cohen","year":"2010","unstructured":"Cohen H, Bielorai B, Harats D, et al. Conservative treatment of l-asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia. Pediatr Blood Cancer. 2010;54:703\u20136.","journal-title":"Pediatr Blood Cancer"},{"key":"966_CR9","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1002\/1097-0142(19941215)74:12<3234::AID-CNCR2820741224>3.0.CO;2-1","volume":"74","author":"PG Steinherz","year":"1994","unstructured":"Steinherz PG. Transient, severe hyperlipidemia in patients with acute lymphoblastic leukemia treated with prednisone and asparaginase. Cancer. 1994;74:3234\u20139.","journal-title":"Cancer"},{"key":"966_CR10","unstructured":"Medical Research Council working party on Leukaemia in children, UK National randomised trial for children and young adults with acute lymphoblastic leukaemia (ALL). 2003. http:\/\/www.ctsu.ox.ac.uk\/projects\/leuk\/ukall2003 , UK ALL 2003 Version 7."},{"key":"966_CR11","unstructured":"Wynn DR. Euro- LB 02 Treatment protocol for T-cell and B-precursor cell lymphoblastic lymphoma of the European Inter-group Co-operation on childhood non-Hodgkin-lymphoma (EICNHL), UKCCSG Study. 2004. http:\/\/public.ukcrn.org.uk\/search\/StudyDetail.aspx?StudyID=1480 ."},{"key":"966_CR12","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1136\/bmj.313.7067.1265","volume":"313","author":"P Sharma","year":"1996","unstructured":"Sharma P, Lim S, James D, et al. Pancreatitis may occur with a normal amylase concentration in hypertriglyceridaemia. BMJ. 1996;313:1265.","journal-title":"BMJ"},{"key":"966_CR13","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/(SICI)1097-0142(19980715)83:2<379::AID-CNCR24>3.0.CO;2-P","volume":"83","author":"JM Halton","year":"1998","unstructured":"Halton JM, Nazir DJ, McQueen MJ, Barr RD. Blood lipid profiles in children with acute lymphoblastic leukemia. Cancer. 1998;83:379\u201384.","journal-title":"Cancer"},{"key":"966_CR14","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S0889-8553(21)00513-6","volume":"19","author":"PP Toskes","year":"1990","unstructured":"Toskes PP. Hyperlipidemic pancreatitis. Gastroenterol Clin North Am. 1990;19:783\u201391.","journal-title":"Gastroenterol Clin North Am"},{"key":"966_CR15","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/pbc.21037","volume":"49","author":"HM Knoderer","year":"2007","unstructured":"Knoderer HM, Robarge J, Flockhart DA. Predicting asparaginase-associated pancreatitis. Pediatr Blood Cancer. 2007;49:634\u20139.","journal-title":"Pediatr Blood Cancer"},{"key":"966_CR16","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1097\/MPH.0b013e3181b87035","volume":"31","author":"S Treepongkaruna","year":"2009","unstructured":"Treepongkaruna S, Thongpak N, Pakakasama S, et al. Acute pancreatitis in children with acute lymphoblastic leukemia after chemotherapy. J Pediatr Hematol Oncol. 2009;31:812\u20135.","journal-title":"J Pediatr Hematol Oncol"},{"key":"966_CR17","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1001\/archinte.1970.00310010131015","volume":"125","author":"JD Bagdade","year":"1970","unstructured":"Bagdade JD, Porte D, Bierman EL. Steroid-induced lipemia. A complication of high-dosage corticosteroid therapy. Arch Intern Med. 1970;125:129\u201334.","journal-title":"Arch Intern Med"},{"key":"966_CR18","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/sj.leu.2400703","volume":"11","author":"N Hoogerbrugge","year":"1997","unstructured":"Hoogerbrugge N, Jansen H, Hoogerbrugge PM. Transient hyperlipidemia during treatment of ALL with l-asparaginase is related to decreased lipoprotein lipase activity. Leukemia. 1997;11:1377\u20139.","journal-title":"Leukemia"},{"key":"966_CR19","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/MOL.0b013e3283319a1d","volume":"20","author":"N Ewald","year":"2009","unstructured":"Ewald N, Hardt PD, Kloer HU. Severe hypertriglyceridemia and pancreatitis: presentation and management. Curr Opin Lipidol. 2009;20:497\u2013504.","journal-title":"Curr Opin Lipidol"},{"key":"966_CR20","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1542\/peds.2006-0787","volume":"119","author":"B Belay","year":"2007","unstructured":"Belay B, Belamarich PF, Tom-Revzon C. The use of statins in pediatrics: knowledge base, limitations, and future directions. Pediatrics. 2007;119:370\u201380.","journal-title":"Pediatrics"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-011-0966-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-011-0966-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-011-0966-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,15]],"date-time":"2021-12-15T00:53:52Z","timestamp":1639529632000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-011-0966-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,8]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["966"],"URL":"https:\/\/doi.org\/10.1007\/s12185-011-0966-9","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,8]]}}}